GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of reading New Zealand threads from 2024 and half of it aged badly — 64 comments in the full submission. View in context.
1.3k
c/glp1aus·submitted 1 year ago by u/viktor_girard

reading New Zealand threads from 2024 and half of it aged badly

Pricingbranch of 7 comments

Something I keep coming back to: reading New Zealand threads from 2024 and half of it aged badly. Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other. Personal importation provisions exist, are narrow, and carry…

Read the full submission and all 64 comments →

This branch

7 comments, started 1 year ago
u/lane_watchermod · logistics309 points·1 year ago

Subsidy criteria and authority requirements are published. For eligibility questions those documents are authoritative and this board is not.

replysharereportpermalink
u/sten_bhattacharya129 points·1 year ago

Checked the shortage database myself instead of reading the coverage. Expected resolution date was right there and the panic thread was wrong.

replysharereportpermalink
[deleted]51 points·1 year ago

[deleted]

replysharereportpermalink
u/adaeze_batista65 points·1 year ago

keep the script and the receipt for private health claims

replysharereportpermalink
u/viktor_laurent52 points·1 year ago

Small fix — that is the New Zealand arrangement, and the question is about Australia.

replysharereportpermalink
u/viktor_girardOP41 points·1 year ago

Which indication is the script written for?

replysharereportpermalink
u/pavel_halvorsen15 points·1 year ago

the Medsafe position in New Zealand is its own thing entirely

replysharereportpermalink

← back to the whole thread

About c/glp1aus

Australia and New Zealand: PBS listing status and what it does to out-of-pocket cost, TGA shortage notices, the 2024 compounding rule change that closed a major access route overnight, and NZ's unfunded-means-full-price reality.

20kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1aus rules
  1. PBS/TGA claims need the notice or the schedule entry.
  2. AU and NZ are different systems. Say which.
  3. No naming compounders operating against the current rules.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.